Effects of bacterial superantigens on behavior of mice in the elevated plus maze and light-dark box

Brain, Behavior, and Immunity

Volumn 18, Issue 1, 2004, Pages 46-54

  Rossi George, Alba ^a   LeBlanc, Fred ^a   Kaneta, Takehiro ^a   Urbach, Daniella ^a   Kusnecov, Alexander W ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DARKNESS; EXPLORATORY BEHAVIOR; FOOD INTAKE; GUSTATORY SYSTEM; LATENT PERIOD; LIGHT; MALE; MAZE TEST; MOUSE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TASK PERFORMANCE;

EID: 0344825119     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(03)00087-4     Document Type: Article

References (39)

1. Acuto O., Meo T. TCR V beta genes in man and mouse and the factors that shape the linkage pattern of immune receptor genes. Immunol. Today. 10:1989;14-17.
2. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125:2001;141-149.
3. Bette M., Schafer M.K., van Rooijen N., Weihe E., Fleischer B. Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J. Exp. Med. 178:1993;1531-1539.
4. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84:1998;923-933.
5. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.F., Vale W., Gold L.H. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res. 835:1999;1-9.
6. Dellabona P., Peccoud J., Kappler J., Marrack P., Benoist C., Mathis D. Superantigens interact with MHC class II molecules 'outside of the antigen groove'. Cell. 62:1990;1115-1121.
7. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav. Brain Res. 125:2001;151-157.
8. Goehler L.E., Gaykema R.P., Hansen M.K., Kleiner J.L., Maier S.F., Watkins L.R. Staphylococcal enterotoxin B induces fever, brain c-Fos expression, and serum corticosterone in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:2001;R1434-R1439.
9. Gonzalez-Quintial R., Baccala R., Balderas R.S., Theofilopoulos A.N. V beta gene repertoire in the aging mouse: a developmental perspective. Int. Rev. Immunol. 12:1995;27-40.
10. Gonzalo J.A., Gonzalez-Garcia A., Martinez C., Kroemer G. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J. Exp. Med. 177:1993;1239-1246.
11. Hennessy M.B. Sensitization of the plasma corticosterone response to novel environments. Physiol. Behav. 50:1991;1175-1179.
12. Herman A., Kappler J.W., Marrack P., Pullen A.M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:1991;745-772.
13. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
14. Holmes A., Iles J.P., Mayell S.J., Rodgers R.J. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav. Brain Res. 122:2001;159-167.
15. Hong S.C., Waterbury G., Janeway C.A. Jr. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor. J. Exp. Med. 183:1996;1437-1446.
16. Irwin J., Ahluwalia P., Zacharko R.M., Anisman H. Central norepinephrine and plasma corticosterone following acute and chronic stressors: influence of social isolation and handling. Pharmacol. Biochem. Behav. 24:1986;1151-1154.
17. Kawashima N., Kusnecov A.W. Effects of staphylococcal enterotoxin A on pituitary-adrenal activation and neophobic behavior in the C57BL/6 mouse. J. Neuroimmunol. 123:2002;41-49.
18. Kawashima N., Fugate J., Kusnecov A.W. Immunological challenge modulates brain orphanin FQ/nociceptin and nociceptive behavior. Brain Res. 949:2002;71-78.
19. Kopp C., Vogel E., Rettori M.C., Delagrange P., Guardiola-Lemaitre B., Misslin R. Effects of melatonin on neophobic responses in different strains of mice. Pharmacol. Biochem. Behav. 63:1999;521-526.
20. Kusnecov A.W., Liang R., Shurin G. T-lymphocyte activation increases hypothalamic and amygdaloid expression of CRH mRNA and emotional reactivity to novelty. J. Neurosci. 19:1999;4533-4543.
21. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 818:1999;291-303.
22. Lacosta S., Merali Z., Anisman H. Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behav. Neurosci. 113:1999;1030-1041.
23. Llewelyn M., Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2:2002;156-162.
24. Macphail S. Superantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases. Int. Rev. Immunol. 18:1999;141-180.
25. McCormack J.E., Kappler J., Marrack P. Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;2086-2090.
26. Merali Z., Lacosta S., Anisman H. Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res. 761:1997;225-235.
27. Merali Z., McIntosh J., Kent P., Michaud D., Anisman H. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J. Neurosci. 18:1998;4758-4766.
28. Misslin R., Herzog F., Koch B., Ropartz P. Effects of isolation, handling and novelty on the pituitary-adrenal response in the mouse. Psychoneuroendocrinology. 7:1982;217-221.
29. Montkowski A., Landgraf R., Yassouridis A., Holsboer F., Schobitz B. Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacol. Biochem. Behav. 58:1997;329-336.
30. Pelleymounter M.A., Joppa M., Ling N., Foster A.C. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress. J. Pharmacol. Exp. Ther. 302:2002;145-152.
31. Petitto J.M., McCarthy D.B., Rinker C.M., Huang Z., Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 73:1997;183-190.
32. Rodgers R.J., Cole J.C., Aboualfa K., Stephenson L.H. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;805-813.
33. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 21:1997;801-810.
34. Shurin G., Shanks N., Nelson L., Hoffman G., Huang L., Kusnecov A.W. Hypothalamic-pituitary-adrenal activation by the bacterial superantigen staphylococcal enterotoxin B: role of macrophages and T cells. Neuroendocrinology. 65:1997;18-28.
35. Sim G.K., MacNeil I.A., Augustin A.A. T helper cell receptors: idiotypes and repertoire. Immunol. Rev. 90:1986;49-72.
36. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14:1994;2579-2584.
37. Sundstedt A., Dohlsten M., Hedlund G., Hoiden I., Bjorklund M., Kalland T. Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology. 82:1994;117-125.
38. Yagi J.J., Rath S., Janeway C.A. Jr. Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism. J. Immunol. 147:1991;1398-1405.
39. Zalcman S.S. Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity. Brain Res. 899:2001;1-9.